日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BLIMP1 negatively regulates IL-2 signaling in T cells

BLIMP1负调控T细胞中的IL-2信号传导

Suyasha Roy,Min Ren,Peng Li,Kairong Cui,Yaqiang Cao,Bryan Fisk,Tovah E Markowitz,Neelam Redekar,Keiko Sakamoto,Keisuke Nagao,Jangsuk Oh,Rosanne Spolski,Wei Liao,Sigrid P Dubois,Brian L Kelsall,Keji Zhao,James D Phelan,Warren J Leonard

Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies

白细胞介素-15增强了CD52+ T细胞恶性肿瘤患者中阿仑单抗的NK细胞介导的ADCC作用

Miljkovic, Milos D; Dubois, Sigrid P; Müller, Jürgen R; Bryant, Bonita; Ma, Elaine; Conlon, Kevin C; Waldmann, Thomas A

A very long-acting IL-15: implications for the immunotherapy of cancer

超长效 IL-15:对癌症免疫治疗的意义

John A Hangasky, Wei Chen #, Sigrid P Dubois #, Anusara Daenthanasanmak #, Jürgen R Müller, Ralph Reid, Thomas A Waldmann #, Daniel V Santi #

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

短期持续输注IL-15可导致有效NK细胞大量扩增:对联合抗肿瘤抗体治疗的启示

Dubois, Sigrid P; Miljkovic, Milos D; Fleisher, Thomas A; Pittaluga, Stefania; Hsu-Albert, Jennifer; Bryant, Bonita R; Petrus, Michael N; Perera, Liyanage P; Müller, Jürgen R; Shih, Joanna H; Waldmann, Thomas A; Conlon, Kevin C

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma

靶向成人T细胞白血病/淋巴瘤中HTLV-I调控的BATF3/IRF4转录网络

Masao Nakagawa ,Arthur L Shaffer 3rd ,Michele Ceribelli ,Meili Zhang ,George Wright ,Da Wei Huang ,Wenming Xiao ,John Powell ,Michael N Petrus ,Yibin Yang ,James D Phelan ,Holger Kohlhammer ,Sigrid P Dubois ,Hee Min Yoo ,Emmanuel Bachy ,Daniel E Webster ,Yandan Yang ,Weihong Xu ,Xin Yu ,Hong Zhao ,Bonita R Bryant ,Joji Shimono ,Takashi Ishio ,Michiyuki Maeda ,Patrick L Green ,Thomas A Waldmann ,Louis M Staudt

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer

重组人白细胞介素-15 在癌症患者中首次人体临床试验期间的重新分布、过度增殖、自然杀伤细胞和 CD8 T 细胞的激活以及细胞因子的产生

Kevin C Conlon, Enrico Lugli, Hugh C Welles, Steven A Rosenberg, Antonio Tito Fojo, John C Morris, Thomas A Fleisher, Sigrid P Dubois, Liyanage P Perera, Donn M Stewart, Carolyn K Goldman, Bonita R Bryant, Jean M Decker, Jing Chen, Tat'Yana A Worthy, William D Figg Sr, Cody J Peer, Michael C Sneller